Impact of digital health on Type 2 diabetes management: a randomised controlled trial of the 'TreC Diabete' platform (TELEMECHRON Study)
- PMID: 40557310
- PMCID: PMC12186056
- DOI: 10.3389/fcdhc.2025.1589548
Impact of digital health on Type 2 diabetes management: a randomised controlled trial of the 'TreC Diabete' platform (TELEMECHRON Study)
Abstract
Background: The use of technologies in the health field has progressively increased. Within the context of a broader project funded by the Italian Ministry of Health (TELEMECHRON study), a randomised controlled trial (RCT) has been conducted in the Autonomous Province of Trento on type 2 diabetes individuals with an untargeted glycated haemoglobin (HbA1c) level.
Methods: The overall aim was to evaluate the impact of the "TreC Diabete" digital platform, including a smartphone application (app) and a dashboard. This open-label, parallel-group, 1:1 allocation ratio RCT in which the intervention group used the app for data entry, symptoms questionnaire, communication with healthcare staff and medication recording, while the control group received standard care. The primary endpoint was change in HbA1c levels at 12 months between groups.
Results: Between December 2022 and August 2023, 103 participants were enrolled (51 intervention; 52 control), with a median age of 67 years old, time from diabetes diagnosis to enrolment 13 years, and 72% male. At 12 months, the median change in HbA1c levels did not differ significantly between groups. Regarding app usage, data entries decreased significantly from the first quarter to the second quarter but subsequently stabilised (p = 0.001). System usability (from 42 responders in the intervention group) had a median score of 95 (range: 0-100), indicating a high level of satisfaction with the platform.
Discussion: The study faced several challenges, including platform technical issues, service interruption, data entry anomalies and difficulties in participant recruitment. Study generalisability may be limited by the sample's demographics, as the trial predominantly included younger male individuals with a specific HbA1c level.
Conclusion: The study highlighted key factors for future implementations, including understanding technology benefits, addressing adoption barriers, and providing education and support to both patients and healthcare providers.
Keywords: digital health; mHealth; metabolic control; randomised controlled trial; telemedicine; type 2 diabetes.
Copyright © 2025 Giovanazzi, Gios, Gentilini, Mastellaro, Bartolotta, Nicolussi Giacomaz, Eccher and Inchiostro.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Computer and mobile technology interventions for self-management in chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2017 May 23;5(5):CD011425. doi: 10.1002/14651858.CD011425.pub2. Cochrane Database Syst Rev. 2017. PMID: 28535331 Free PMC article.
-
Exploring engagement patterns within a mobile health intervention for women at risk of gestational diabetes.Womens Health (Lond). 2025 Jan-Dec;21:17455057251327510. doi: 10.1177/17455057251327510. Epub 2025 Jun 5. Womens Health (Lond). 2025. PMID: 40470610 Free PMC article. Clinical Trial.
-
Treatments for seizures in catamenial (menstrual-related) epilepsy.Cochrane Database Syst Rev. 2021 Sep 16;9(9):CD013225. doi: 10.1002/14651858.CD013225.pub3. Cochrane Database Syst Rev. 2021. PMID: 34528245 Free PMC article.
-
Home treatment for mental health problems: a systematic review.Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150. Health Technol Assess. 2001. PMID: 11532236
-
Eliciting adverse effects data from participants in clinical trials.Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2. Cochrane Database Syst Rev. 2018. PMID: 29372930 Free PMC article.
References
-
- Diabete - EpiCentro - Istituto Superiore di Sanità . Available online at: https://www.epicentro.iss.it/diabete/ (Accessed 24/Jan/2025).
-
- World Health Organization . Global report on diabetes. Geneva: World Health Organization; (2016), ISBN: 978 92 4 156525.
LinkOut - more resources
Full Text Sources